RENOVA, Inc.
RENOVA, Inc. (9519.T) Financial Performance & Income Statement Overview
Analyze RENOVA, Inc. (9519.T) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
RENOVA, Inc. (9519.T) Income Statement & Financial Overview
Access detailed annual and quarterly income data for RENOVA, Inc. 9519.T financial performance.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $21.61B | $14.99B | $18.53B | $15.16B |
| Cost of Revenue | $15.14B | $6.81B | $14.59B | $11.99B |
| Gross Profit | $6.48B | $2.92B | $3.94B | $2.13B |
| Gross Profit Ratio | $0.30 | $0.19 | $0.21 | $0.14 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $5.32B | $2.27B | $0.00 | $0.00 |
| Operating Expenses | $5.06B | $2.80B | $3.60B | $2.95B |
| Total Costs & Expenses | $20.20B | $14.62B | $14.59B | $13.02B |
| Interest Income | $0.00 | $607.00M | $89.00M | $961.00M |
| Interest Expense | $1.59B | $1.33B | $1.62B | $1.35B |
| Depreciation & Amortization | $4.26B | $4.10B | $4.08B | $4.07B |
| EBITDA | $9.78B | $4.20B | $5.57B | $4.28B |
| EBITDA Ratio | $0.45 | $0.28 | $0.30 | $0.28 |
| Operating Income | $1.41B | $377.00M | $3.94B | $2.13B |
| Operating Income Ratio | $0.07 | $0.03 | $0.21 | $0.14 |
| Other Income/Expenses (Net) | $2.43B | -$712.00M | -$3.87B | -$1.94B |
| Income Before Tax | $3.84B | -$335.00M | $71.00M | $200.00M |
| Income Before Tax Ratio | $0.18 | -$0.02 | $0.004 | $0.01 |
| Income Tax Expense | $247.00M | $175.00M | $180.00M | $142.00M |
| Net Income | $3.60B | -$783.00M | -$459.00M | $331.00M |
| Net Income Ratio | $0.17 | -$0.05 | -$0.02 | $0.02 |
| EPS | $39.80 | -$8.66 | -$5.08 | $3.73 |
| Diluted EPS | $39.59 | -$8.66 | -$5.07 | $3.73 |
| Weighted Avg Shares Outstanding | $90.91M | $90.42M | $90.41M | $88.76M |
| Weighted Avg Shares Outstanding (Diluted) | $90.90M | $90.42M | $90.47M | $88.76M |
Over the last four quarters, RENOVA, Inc. achieved steady financial progress, growing revenue from $15.16B in Q1 2024 to $21.61B in Q4 2024. Gross profit stayed firm with margins at 30% in Q4 2024 versus 14% in Q1 2024. Operating income totaled $1.41B in Q4 2024, maintaining a 7% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at $9.78B. Net income rose to $3.60B, with EPS at $39.80. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan